Showing 1 - 10 of 12
Theories of vertical restraints have shown that vertical practices have the potential to harm competition. Although (or because) they are based on more realistic market structures and account explicitly for strategic interactions among competitions, the predictions of these models are...
Persistent link: https://www.econbiz.de/10014061892
The legality of nonprice vertical practices in the U.S. is determined by their likely competitive effects. An optimal enforcement rule combines evidence with theory to update prior beliefs, and specifies a decision that minimizes the expected loss. Because the welfare effects of vertical...
Persistent link: https://www.econbiz.de/10014028121
The legality of nonprice vertical practices in the U.S. is determined by their likely competitive effects. An optimal enforcement rule combines evidence with theory to update prior beliefs, and specifies a decision that minimizes the expected loss. Because the welfare effects of vertical...
Persistent link: https://www.econbiz.de/10014028139
Persistent link: https://www.econbiz.de/10001353450
Persistent link: https://www.econbiz.de/10001069644
Persistent link: https://www.econbiz.de/10001790481
Persistent link: https://www.econbiz.de/10001525666
The nature, and normative properties, of competition in health care markets has long been the subject of much debate. In particular, policymakers have exhibited a great deal of reservation toward competition in health care markets, as demonstrated by the plethora of regulations governing the...
Persistent link: https://www.econbiz.de/10013235279
The nature, and normative properties, of competition in health care markets has long been the subject of much debate. In particular, policymakers have exhibited a great deal of reservation toward competition in health care markets, as demonstrated by the plethora of regulations governing the...
Persistent link: https://www.econbiz.de/10012471947
The nature, and normative properties, of competition in health care markets has long been the subject of much debate. In this paper we consider what the optimal benchmark is in the presence of moral hazard effects on consumption due to health insurance. Intuitively, it seems that imperfect...
Persistent link: https://www.econbiz.de/10014149528